Definition: A Quality-Adjusted Life Year (QALY) is a generic measure of disease burden, combining both the quantity and quality of life lived. It represents one year of life lived in perfect health.
QALYs are calculated by multiplying the number of years an individual is expected to live by a utility weight, which reflects the quality of life during those years. This utility weight typically ranges from 0 (representing death) to 1 (representing perfect health), with values between 0 and 1 indicating varying states of imperfect health. For example, living for one year in a health state valued at 0.5 would equate to 0.5 QALYs, as would living for half a year in perfect health. These utility weights are often derived from patient or public preferences using methods such as time trade-off, standard gamble, or visual analogue scales, providing a standardized way to quantify the value of different health states.
In public health and health economics, QALYs are primarily used in cost-effectiveness analyses (CEA) to evaluate the value for money of different health interventions, treatments, and prevention programs. By providing a common unit that accounts for both survival and quality of life, QALYs allow for comparisons across diverse health conditions and interventions, helping decision-makers allocate scarce healthcare resources efficiently. While widely adopted by health technology assessment (HTA) bodies globally, QALYs also face ethical criticisms regarding the valuation of life, potential discrimination against certain patient groups (e.g., the elderly or chronically ill), and the inherent subjectivity in assigning utility weights to health states.
Key Context:
- Cost-Effectiveness Analysis (CEA): QALYs serve as the primary outcome measure in CEA, enabling the comparison of the costs and benefits of different healthcare interventions.
- Utility Weights: These numerical values (0-1) represent the preference for a particular health state and are fundamental to the calculation of QALYs.
- Health Technology Assessment (HTA): Organizations like the National Institute for Health and Care Excellence (NICE) in the UK use QALYs extensively in HTA to inform decisions about funding new drugs and treatments.